News | January 07, 2026
Dr. Lal PathLabs launches tech-driven personalized wellness center 'Sovaaka'
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Heart failure affects an estimated 64.3 million people worldwide
GlideTech materials are available in several standard base resins and offer customization options for specific applications
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
India’s pharmaceutical sector stands at a pivotal inflection point
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Subscribe To Our Newsletter & Stay Updated
